These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6315314)

  • 21. Alterations of mitogenic responses of mononuclear cells by arsenic in arsenical skin cancers.
    Yu HS; Chang KL; Wang CM; Yu CL
    J Dermatol; 1992 Nov; 19(11):710-4. PubMed ID: 1293158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
    Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR
    Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arsenic-induced keratoses and Bowen's disease.
    Watson K; Creamer D
    Clin Exp Dermatol; 2004 Jan; 29(1):46-8. PubMed ID: 14723721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Arsenic-Induced Bowen’s Disease With Topical 5-Fluorouracil.
    Verhave B; Goldberg M; Hashim P; Levitt J
    J Drugs Dermatol; 2019 May; 18(5):477-479. PubMed ID: 31141858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic study of arsenic-induced skin lesions: no definite association with human papillomavirus.
    Ratnam KV; Espy MJ; Muller SA; Smith TF; Su WP
    J Am Acad Dermatol; 1992 Jul; 27(1):120-2. PubMed ID: 1320060
    [No Abstract]   [Full Text] [Related]  

  • 26. Merkel cell carcinoma and multiple Bowen's disease: incidental association or possible relationship to inorganic arsenic exposure?
    Ohnishi Y; Murakami S; Ohtsuka H; Miyauchi S; Shinmori H; Hashimoto K
    J Dermatol; 1997 May; 24(5):310-6. PubMed ID: 9198320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic cutaneous arsenism treated with aromatic retinoid.
    Thianprasit M
    J Med Assoc Thai; 1984 Feb; 67(2):93-100. PubMed ID: 6736831
    [No Abstract]   [Full Text] [Related]  

  • 28. Arsenic exposure followed by the development of dermatofibrosarcoma protuberans.
    Shneidman D; Belizaire R
    Cancer; 1986 Oct; 58(7):1585-7. PubMed ID: 3742477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of oxidative DNA damage in human arsenic carcinogenesis: detection of 8-hydroxy-2'-deoxyguanosine in arsenic-related Bowen's disease.
    Matsui M; Nishigori C; Toyokuni S; Takada J; Akaboshi M; Ishikawa M; Imamura S; Miyachi Y
    J Invest Dermatol; 1999 Jul; 113(1):26-31. PubMed ID: 10417614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Palmoplantar keratoses and Bowen's disease in a Vietnam veteran: Could Agent Blue be implicated?
    Cognetta AB; Wolfe CM; Herbst AT
    Australas J Dermatol; 2016 May; 57(2):e66-8. PubMed ID: 26299801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial biogenesis drives tumor cell proliferation.
    Martinez-Outschoorn UE; Pavlides S; Sotgia F; Lisanti MP
    Am J Pathol; 2011 May; 178(5):1949-52. PubMed ID: 21514412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arsenic-related Bowen's disease and paraquat-related skin cancerous lesions show no detectable ras and p53 gene alterations.
    Hsieh LL; Chen HJ; Hsieh JT; Jee SH; Chen GS; Chen CJ
    Cancer Lett; 1994 Oct; 86(1):59-65. PubMed ID: 7954356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant immune responses in arsenical skin cancers.
    Lee CH; Liao WT; Yu HS
    Kaohsiung J Med Sci; 2011 Sep; 27(9):396-401. PubMed ID: 21914527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of mtDNA damage elicited by oxidative stress in the arsenical skin cancers.
    Lee CH; Wu SB; Hong CH; Chen GS; Wei YH; Yu HS
    J Invest Dermatol; 2013 Jul; 133(7):1890-900. PubMed ID: 23370535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple Bowen's diseases and basal cell carcinomas in a patient with acute promyelocytic leukemia treated with arsenic trioxide: A case report and effective treatment with photodynamic therapy.
    Ding C; Ma YY; Wang P; Liu J
    Dermatol Ther; 2018 Nov; 31(6):e12718. PubMed ID: 30239071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple cutaneous precanceroses and carcinomas from combined iatrogenic/professional exposure to arsenic.
    Torchia D; Massi D; Caproni M; Fabbri P
    Int J Dermatol; 2008 Jun; 47(6):592-3. PubMed ID: 18477152
    [No Abstract]   [Full Text] [Related]  

  • 37. Photodye herpes therapy--Cassandra confirmed?
    Berger RS; Papa CM
    JAMA; 1977 Jul; 238(2):133-4. PubMed ID: 577281
    [No Abstract]   [Full Text] [Related]  

  • 38. Progressive alterations of cytokeratin expressions in the process of chronic arsenism.
    Yu HS; Chiou KS; Chen GS; Yang RC; Chang SF
    J Dermatol; 1993 Dec; 20(12):741-5. PubMed ID: 7509818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence of the Merkel cell polyomavirus in Merkel cell carcinoma combined with squamous cell carcinoma in a patient with chronic arsenism.
    Chou TC; Tsai KB; Wu CY; Hong CH; Lee CH
    Clin Exp Dermatol; 2016 Dec; 41(8):902-905. PubMed ID: 27774637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Syntopy of Bowen's disease and Lewisite scar].
    Krause H; Grussendorf EI
    Hautarzt; 1978 Sep; 29(9):490-3. PubMed ID: 697984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.